Spots Global Cancer Trial Database for Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis

Official Title: Prospective Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis

Study ID: NCT03847220

Conditions

Breast Carcinoma Metastatic to the Bone

Interventions

BOMET-QoL questionnaire

Study Description

Brief Summary: Epidemiological, prospective and multicenter study to evaluate the utility of the BOMET-QoL questionnaire in patients with breast cancer (BC) and bone metastases (BM).

Detailed Description: Population: Patients over 18 with breast cancer and bone metastasis. Inclusion criteria: * Patient over 18 years of age. * Patient diagnosed with breast cancer (BC) and bone metastases (BM). * Patient who has granted informed consent in writing to participate in the study. * Patient capable of understanding and completing the questionnaires. Exclusion criteria: * Patient with another type of disease that, in the investigator's opinion, could mask the study results. * Patients with a life expectancy of less than 8 months. * Patient who is participating in a clinical trial with an unregistered drug at the start of the study.